CausalSentinel

Protein Dossier — GNRH2 (Progonadoliberin-2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: polio or poliomyelitis 0.843 0.248 6.67e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.112 0.0351 0.00137 Wald ratio 1 cis NA
Diagnoses - main ICD10: R04 Haemorrhage from respiratory passages 0.364 0.138 0.00859 Wald ratio 1 cis NA
Parkinson’s disease -0.533 0.233 0.0218 Wald ratio 1 cis NA
Thyroid cancer 0.997 0.458 0.0294 Wald ratio 1 cis NA
Sodium in urine -0.0292 0.0138 0.0339 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.023 0.0115 0.0453 Wald ratio 1 cis NA
Haemoglobin concentration -0.0699 0.035 0.0455 Wald ratio 1 cis NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone 0.251 0.126 0.0459 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids -0.227 0.115 0.0483 Wald ratio 1 cis NA
Body mass index (BMI) 0.0262 0.014 0.0614 Wald ratio 1 cis NA
Putamen volume -61.7 33.1 0.0618 Wald ratio 1 cis NA
…and 83 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

8 association rows across 7 traits (6 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Progonadoliberin-2 levels 2e-134 rs8184100 2 GCST90421204 no MR -> candidate analysis
OXT protein levels 8e-132 rs6115764 1 GCST90470139 no MR -> candidate analysis
Serum levels of protein OXT 2e-28 rs6115763 1 GCST90090149 no MR -> candidate analysis
Oxytocin-neurophysin 1 levels 2e-17 rs6084240 1 GCST90248810 no MR -> candidate analysis
Body mass index 3e-12 rs676749 1 GCST90255621 MR: beta=0.0262, p=0.0614 (cis)
Maximum cranial width 4e-7 rs6115764 1 GCST005940 no MR -> candidate analysis
N-acetyl-beta-alanine levels in elite athletes 7e-6 rs8125955 1 GCST90134018 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

No genetically-associated diseases retrieved from Open Targets.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=9.3e-07, LOEUF=1.9 — LoF-tolerant
GWAS Catalog 75 unique SNPs / 149 rows
ClinVar 63 records; 6 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance